Articles From: Bioniche Life Sciences Inc. to Publish Comprehensive Phase 3 Clinical Trial Results In The Journal of Urology to Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results


2014/10/10
Bioniche Life Sciences Inc. to Publish Comprehensive Phase 3 Clinical Trial Results In The Journal of Urology Canada NewsWire The data reported in this publication pertains to pivotal Phase 3 study conducted with MCNA (Mycobacterium phlei cell wall-nucleic acid complex) and includes results of planned statistical analyses at study completion including efficacy rates at 3 and 6 months and 2 years after therapy.
Sign-up for Bioniche Life Sciences Inc. to Publish Comprehensive Phase 3 Clinical Trial Results In The Journal of Urology investment picks
http://media.marketwire.com/attachments/201312/69900_StockMarketMediaLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145119&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Bioniche Life Sciences Receives Coverage as Highly Undervalued Biopharmaceutical investment picks
2014/10/22
http://media.marketwire.com/attachments/201407/263939_BION-ID-Horiz-RGB-300DPI-TM.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153188&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen Announces Operational Update for Florida Plants investment picks
2014/9/8
http://media.marketwire.com/attachments/201407/263939_BION-ID-Horiz-RGB-300DPI-TM.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141874&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen Appoints Paul B. Savoldelli to Its Board investment picks
2014/9/4
http://media.marketwire.com/attachments/201409/78876_bion.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142005&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen Enters Into a $5 Million Loan for Taylor County Plant investment picks
2014/9/24
http://media.marketwire.com/attachments/201407/263939_BION-ID-Horiz-RGB-300DPI-TM.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147007&ProfileId=051205&sourceType=1 WEST PALM BEACH, FL --
Sign-up for BioNitrogen President & CFO to Take Leave of Absence investment picks
2014/7/29
BOSTON , MASS., July 29, 2014 (GLOBE NEWSWIRE) -- Polaris Partners today announced the hiring of biopharmaceutical executive Amy Schulman as a Venture Partner, based out of Boston.
Sign-up for BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS investment picks
2014/10/2
CARLSBAD, Calif.
Sign-up for BioPop Releases a Living, Bioluminescent Dinosaur: The Dino Pet investment picks
ELMWOOD PARK, N.J., Aug.
Sign-up for BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2014 investment picks
ELMSFORD, N.Y. , Aug.
Sign-up for BioScrip Reports Second Quarter 2014 Financial Results investment picks
ELMSFORD, N.Y. , Oct.
Sign-up for BioScrip To Host Third Quarter 2014 Earnings Call investment picks
2014/8/6
SINGAPORE , Aug.
Sign-up for Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015 investment picks
ADVISORY, July 22, 2014 (GLOBE NEWSWIRE) -- What: BioSpecifics Technologies Corp (Nasdaq:BSTC) , a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date, will visit the NASDAQ MarketSite in Times Square.
Sign-up for BioSpecifics Technologies Corp (NASDAQ: BSTC) to Ring the NASDAQ Stock Market Opening Bell investment picks
- Label expansion to broaden patient base who may benefit from nonsurgical collagenase therapy LYNBROOK, N.Y. , Oct.
Sign-up for BioSpecifics Technologies Corp. Announces FDA Approval of sBLA for XIAFLEX® for the Concurrent Treatment of Two Dupuytren's Contracture Cords investment picks
- Data suggest support for potential label expansion of XIAFLEX for Dupuytren's contracture to include treatment of two affected joints concurrently; PDUFA date is October 20, 2014 - LYNBROOK, N.Y. , Sept.
Sign-up for BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting investment picks
LYNBROOK, N.Y. , Sept.
Sign-up for BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences investment picks
LYNBROOK, N.Y. , Oct.
Sign-up for BioSpecifics Technologies Corp. Announces Sudden Passing of Director Max Link, Ph.D. investment picks
LYNBROOK, N.Y. , Aug.
Sign-up for BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results investment picks
-- Revenue increased by 31% to $19.2 million --
Sign-up for Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Bioniche Life Sciences Inc. to Publish Comprehensive Phase 3 Clinical Trial Results In The Journal of Urology to Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices